• <em>N</em>⁴ -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
• <em>Pteropus vampyrus</em> TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors
• A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus
• A novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle
• A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramer
• A Revised Diagnostic Quantitative RT-PCR for the Detection of Nipah Virus Infection
• A Survey of Henipavirus Tropism-Our Current Understanding from a Species/Organ and Cellular Level
• A systematic review on Nipah virus: global molecular epidemiology and medical countermeasures development
• A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
• Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics
• Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus
• An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus
• An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus
• An mRNA-based reverse-vaccinology strategy to stimulate the immune response against Nipah virus in humans using fusion glycoproteins
• An Overview of Conventional and Black Cumin Seeds (<em>Nigella sativa</em>) Therapy in the Management of Nipah Viral Infection
• An Overview of Conventional and Black Cumin Seeds (Nigella sativa) Therapy in the Management of Nipah Viral Infection
• Animal Models for Henipavirus Research
• Biological Weapon Toxicity
• Central nervous system infections in the tropics
• Characterization of Humoral Responses to Nipah Virus Infection in the Syrian Hamster Model of Disease
• Clinico-epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023
• Common and Potential Emerging Foodborne Viruses: A Comprehensive Review
• Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8
• Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials
• Current status of diagnostic assays for emerging zoonotic viruses: Nipah and Hendra
• Discovery and genetic characterization of novel paramyxoviruses from small mammals in Hubei Province, Central China
• Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses
• Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge
• Ethical issues in Nipah virus control and research: addressing a neglected disease
• Etiology of Meningoencephalitis in children aged less than 5 years
• Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs
• Ferret Models for Henipavirus Infection
• Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination
• Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein
• Generation of a Porcine Cell Line Stably Expressing Pig TMPRSS2 for Efficient Isolation of Swine Influenza Virus
• Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis
• Henipavirus naming and regional discrimination
• Henipavirus zoonosis: outbreaks, animal hosts and potential new emergence
• Henipavirus-induced neuropathogenesis in mice
• Horse populations are severely underestimated in a region at risk of Hendra virus spillover
• Host Transcriptome Analysis of Ferret Tissues Following Henipavirus Infection
• Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
• In silico prediction of interaction between Nipah virus attachment glycoprotein and host cell receptors Ephrin-B2 and Ephrin-B3 in domestic and peridomestic mammals
• In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus
• In Vivo Imaging of Nipah Virus Infection in Small Animal Rodent Models
• Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice
• Indiscriminate activities of different henipavirus polymerase complex proteins allow for efficient minigenome replication in hybrid systems
• Infection and transmission of henipavirus in animals
• Isolation of Primary Porcine Bronchial Epithelial Cells for Nipah Virus Infections
• Langya henipavirus outbreak
• Mapping the distribution of Nipah virus infections: a geospatial modelling analysis
• Mouse Models of Henipavirus Infection
• Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus
• N(4) -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
• Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV
• Nipah virus disease: what can we do to improve patient care?
• NIPAH Virus Encephalitis: Unveiling the Epidemiology, Risk Factors, and Clinical Outcomes - A Systematic Review and Meta-Analysis
• Nipah virus is deadly - but smart policy changes can help quell pandemic risk
• Nipah Virus Neurotropism: Insights into Blood-Brain Barrier Disruption
• Nipah virus-associated neuropathology in African green monkeys during acute disease and convalescence
• Nipah Virus: A Multidimensional Update
• Nipah virus: a re-emerging public health concern
• Nipah virus: an ever-present threat
• Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries
• Nipah: The looming post-covid pandemic
• Novel "GaEl Antigenic Patches" Identified by a "Reverse Epitomics" Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human Health
• Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle
• Optimal control analysis for the Nipah infection with constant and time-varying vaccination and treatment under real data application
• Outcome and Sequelae of Infectious Encephalitis
• Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection
• Pathogenicity and virulence of henipaviruses
• Possible high risk of transmission of the Nipah virus in South and South East Asia: a review
• Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains
• Potential for Person-to-Person Transmission of Henipaviruses: A Systematic Review of the Literature
• Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics
• Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics
• Prefusion stabilization of the Hendra and Langya virus F proteins
• Primary Culture of the Human Olfactory Neuroepithelium and Utilization for Henipavirus Infection In Vitro
• Profiling Host MicroRNA Responses to Henipavirus Infection
• Recently Emerged Novel Henipa-like Viruses: Shining a Spotlight on the Shrew
• Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness
• Research on emerging infectious diseases: pros and cons of centralised government controls
• Saliva: An Overlooked yet Critical Diagnostic Tool in Detection of Nipah Virus
• Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins
• Severe zoonotic viruses carried by different species of bats and their regional distribution
• Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
• South Asia's Strategic Readiness Amidst Worsening Nipah Virus Threats: Current Situation and Imperatives
• Structural Studies of Henipavirus Glycoproteins
• Structure and design of Langya virus glycoprotein antigens
• Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes
• Surveillance of Nipah virus in Pteropus medius of Kerala state, India, 2023
• Syrian Golden Hamster Model for Nipah Virus Infection
• Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006-2021
• The cryo-EM structure of homotetrameric attachment glycoprotein from langya henipavirus
• The escalation of NiV infection: Epidemiological trends, clinical manifestations, and global implications
• The Nipah virus resurgence 2023: Kerala's resilience in overcoming the outbreak
• Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
• Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV)
• Utilizing Recombinant Reporter Henipaviruses to Conduct Antiviral Screening
• Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection